A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes
Status
Conditions
Treatments
Details and patient eligibility
About
The primary focus of this intervention trial is to understand the effect of quitting smoking on TB treatment outcomes. The investigators will compare a cessation strategy based on guidelines recommended by the World Health Organization (WHO) and the International Union against Tuberculosis and Lung Disease (IUTLD). This is currently not utilized in TB directly observed therapy (DOT) clinics in Pakistan. The investigators study will provide comprehensive data towards understanding the effectiveness of these strategies for TB patients who smoke in Pakistan, and most importantly, on the effect of quitting smoking on TB treatment outcomes. These findings will guide development of effective smoking cessation strategies in a region with high prevalence of TB and increasing tobacco use.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Males, ≥18 years of age
- diagnosed with pulmonary TB
- self-reported current smokers, or smoker within 6 months
- anticipated to be attending the TB treatment clinic for at least 6 months
- be willing to set a quit date within 2 weeks after baseline assessment
- agree to participate
Exclusion criteria
- less than 18 years of age
- quit for more than 6 months
- extra-pulmonary TB
- unable/unwilling to provide written consent
Trial design
Primary purpose
Allocation
Interventional model
Masking
350 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal